What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Ibuprofen, Ibuprofen-Lysine (not indicated in Ductus arteriosus) and Ibuprofen/Caffeine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Beta-alanine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Levosalbutamol, Salbutamol New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Etoposide New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Lomustine New
PSUR-outcome
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Valproate New
Additional template
|
01/12/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Recall
|
Medicines
|
01/12/2023
Recall due to possible foreign body contamination
Recall
|
Medicines
|
30/11/2023
Recall due to difficult removability of the tablets from the blister
30/11/2023
Notification of pet products New Notification of pet products under Article 5(6) of Regulation (EU) 2019/6 New With application of the new European Veterinary Medicinal Products Regulation (EU) 2019/6
messages in brief
Veterinary Medicines
|
30/11/2023
With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.